scholarly article | Q13442814 |
P2093 | author name string | Chao Yu | |
Yifei Ma | |||
Haitao Zhu | |||
Chengyi Sun | |||
Shi Zuo | |||
Zili Chen | |||
Changhao Zhu | |||
Yaozhen Pan | |||
P2860 | cites work | Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss | Q27322590 |
Evolution and functions of long noncoding RNAs | Q29614331 | ||
Management of hepatocellular carcinoma | Q29616230 | ||
Recent advances in hepatocellular carcinoma therapy | Q30236010 | ||
The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA. | Q36316457 | ||
Long Noncoding RNAs in Cancer Pathways | Q36796798 | ||
Long non-coding RNA RP5-833A20.1 inhibits proliferation, metastasis and cell cycle progression by suppressing the expression of NFIA in U251 cells | Q38737303 | ||
RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction | Q42185504 | ||
Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma | Q50065919 | ||
miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2 | Q57165706 | ||
LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway | Q57467173 | ||
MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma | Q64055560 | ||
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma | Q64056207 | ||
The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset | Q64227635 | ||
The Security Rating on Local Ablation and Interventional Therapy for Hepatocellular Carcinoma (HCC) and the Comparison among Multiple Anesthesia Methods | Q64237087 | ||
A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways | Q64285360 | ||
Temporal expression and functional analysis of long non-coding RNAs in colorectal cancer initiation. | Q64921994 | ||
Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC | Q90298858 | ||
[Systemic therapy for hepatocellular carcinoma:recent advances and future perspective] | Q90970479 | ||
MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma | Q92172153 | ||
Identification of a long non‑coding RNA‑mediated competitive endogenous RNA network in hepatocellular carcinoma | Q92582524 | ||
The long noncoding RNA cardiac hypertrophy-related factor plays oncogenic roles in hepatocellular carcinoma by downregulating microRNA-211 | Q92650111 | ||
lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150 | Q92650173 | ||
LncRNA PAPAS promotes hepatocellular carcinoma by interacting with miR-188-5p | Q92668965 | ||
Long Noncoding RNA FER1L4 Suppresses Tumorigenesis by Regulating the Expression of PTEN Targeting miR-18a-5p in Osteosarcoma | Q93343037 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 10717-10726 | |
P577 | publication date | 2019-12-06 | |
P1433 | published in | OncoTargets and Therapy | Q7092081 |
P1476 | title | Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p | |
P478 | volume | 12 |
Search more.